Mpact
Device Hip
General payments
$1,706,326
Research payments
$25,897
Through program year 2023, $1,706,326 in general payments and $25,897 in research payments were reported against Mpact (Hip).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $331,081 | 98 |
| 2022 | General | $403,287 | 50 |
| 2021 | General | $375,220 | 29 |
| 2020 | General | $299,308 | 22 |
| 2020 | Research | $14,957 | 10 |
| 2019 | General | $297,430 | 28 |
| 2019 | Research | $10,940 | 9 |
Breakdown
The top 5 of 28 recipients; each share is of general payments naming this product in 2023.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 15 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
227 general · 19 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.